Replies to post #194665 on Biotech Values

[DewDiligence]

AMGN submits FDA application for Repathta 420mg (monthly-dosing) injector:

http://finance.yahoo.com/news/amgen-submits-application-fda-delivery-131500597.html

Repatha’s initial approval on 8/27/15 (#msg-116560705) included only the 140mg injector, which is intended to be used every two weeks.